Create a narrative

Revvity Community

NYSE:RVTY Community

4 Narratives written by author
0 Comments on narratives written by author
6 Fair Values set on narratives written by author

Create a narrative

AN

AnalystConsensusTarget

Consensus Narrative from 18 Analysts

Genomics England Partnership And T-SPOT Automation Will Drive Diagnostics Leadership

Key Takeaways Strategic partnerships and innovations in genomics and diagnostics position Revvity for strong revenue growth and leadership in these segments. Operational agility and strategic share repurchases are expected to sustain net margins and enhance earnings per share.

US$126.10

FV

25.9% undervalued

6.01%

Revenue growth p.a.

0

0

3

Updated